| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |